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Smad Affinity Can Direct Distinct Readouts
of the Embryonic Extracellular Dpp Gradient
in Drosophila
osa, whereas lower levels of signaling in dorsolateral
and lateral regions specify dorsal epidermis (summa-
rized in Figures 1A and 1B). Dpp/Scw signaling is trans-
duced by the Smad transcription factors, Mad and
Medea [6].
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There are two fundamental questions relating to mor-United Kingdom
phogens. First, how is a morphogen concentration gra-
dient formed, and second, how is the extracellular con-
centration of a morphogen interpreted by cells? In theSummary
case of subdivision of the dorsal ectoderm in the embryo
by Dpp/Scw signaling, much progress has been madeBackground: The TGF- signaling molecule Decapen-
in understanding how the Dpp/Scw concentration gradi-
taplegic (Dpp) is an essential morphogen that patterns
ent is formed [7]. The activities of Dpp and Screw are
many tissues during Drosophila development, including redistributed by a mechanism involving the action of
the embryonic dorsal ectoderm and larval wing imaginal additional extracellular factors, such as short gastrula-
disk. An activity gradient of Dpp specifies distinct cell tion (Sog). sog is expressed in the lateral stripes of the
fates in the dorsal ectoderm of the embryo through the neurogenic ectoderm underlying the dorsal ectoderm
activation of different transcriptional threshold re- (see Figure 1A), and in the absence of Sog there are
sponses. uniform, low levels of Dpp/Scw signaling in the dorsal
Results: We have analyzed the gene Race, which is ectoderm [7].
expressed in response to peak levels of Dpp signaling Although the mechanism of Dpp/Scw gradient forma-
in gastrulating embryos. We show that the Smad tran- tion is generally understood, the answer to the funda-
scription factors, which are intracellular transducers of mental question of how this gradient is interpreted by
Dpp signaling, are essential activators of Race in vivo. target genes to specify distinct cell fates is unknown.
Furthermore, increasing the affinity of the Smad binding Three different thresholds of gene activity have been
sites in the Race enhancer broadens the expression identified in the dorsal ectoderm in response to the Dpp/
pattern of a linked reporter gene and alters its behavior Scw gradient. Threshold I genes, typified by Race, are
in mutant embryos to that characteristic of a distinct only expressed in response to peak levels of Dpp/Scw
threshold response. signaling, whereas type II and III thresholds, such as
Conclusions: Smad activator affinity is a critical deter- tailup (tup) and pannier (pnr), respectively, have broader
minant of the threshold response to the extracellular limits of expression [8]. The pnr expression pattern ex-
Dpp gradient in the embryo. Our results identify a mech- tends throughout the dorsal ectoderm in the central
anism for interpreting the Dpp gradient in the embryo region of the embryo, and its limits are established
which is different to the reciprocal repressor gradient through the action of the Brinker (Brk) repressor, which
model proposed for the wing disk. We suggest that is expressed in the neuroectoderm underlying the dorsal
transcription factor binding site affinity will be a general ectoderm ([9, 10]; Figure 1A). Type I and many type
strategy used in the interpretation of other extracellular II thresholds, however, are Brk independent, and it is
morphogen gradients. unclear how their expression limits are established [8, 9].
Here, we use the Dpp target gene Race in order to
investigate how the limits of a Brk-independent DppIntroduction
threshold response are set. We find that the Race en-
hancer contains binding sites for the Smad transcriptionMorphogens are secreted signaling molecules that pat-
factors, and mutagenesis of these sites abolishes en-tern fields of cells by regulating gene expression in a
hancer activity in the presumptive amnioserosa. In-concentration-dependent manner. Studies in Drosoph-
creasing the affinity of these Smad sites broadens theila and vertebrates have identified members of the
expression pattern driven by the modified enhancer.Hedgehog, Wingless, and TGF- families of signaling
Moreover, this enhancer is able to respond to the lowmolecules as morphogens [1]. Morphogens in the TGF-
levels of Dpp/Scw activity present throughout the dorsalfamily include Activin, BMP4, and Squint, which pattern
ectoderm in sog mutant embryos. Therefore, low Smad
the Xenopus and zebrafish dorsal-ventral axis and regu-
affinity restricts Race expression to only the dorsal most
late embryonic development [2–5]. However, the best-
regions where there is peak Dpp/Scw signaling, identi-
studied TGF- morphogen is the Dpp ligand in Droso- fying a pivotal role for transcriptional activator affinity in
phila, which patterns the dorsal ectoderm in the early the nuclear interpretation of an extracellular morphogen
embryo, as well as the larval wing, eye, and leg imaginal gradient.
disks. The dorsal ectoderm is subdivided into distinct
cell types by an extracellular gradient of Dpp and the Results
related TGF- ligand Screw (Scw). Peak levels of Dpp/
Scw signaling in dorsal-most regions specify amnioser- Dpp Thresholds
Previously, three distinct thresholds of gene expression
in response to the Dpp/Scw gradient were defined in*Correspondence: hilary.ashe@man.ac.uk
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Figure 1. Dpp Threshold Responses
(A) Diagram depicting a side view of an em-
bryo, showing the Dpp gradient in the dorsal
ectoderm (green). Dark green represents
peak Dpp signaling in the presumptive am-
nioserosa (AS). Lighter green colors symbol-
ize lower levels of Dpp signaling, which pro-
mote formation of the dorsal epidermis (DEp).
The neuroectoderm where sog and brk are
expressed is shown in blue.
(B) Dorsal (top) view of an embryo (equivalent
to rotating the view shown in [A] by 90) show-
ing the presumptive amnioserosa (AS) and
dorsal epidermis (DEp) cell fates specified by
the Dpp gradient.
(C–H) Dorsal views of embryos at the initial phase of gastrulation. Embryos were collected from wild-type and mutant strains, then hybridized
with digoxigenin-labeled Race (C–E) or tup (F–H) antisense RNA probes. (C), wild-type embryo: Race is expressed in a narrow strip of cells
in the presumptive amnioserosa. The broader staining in anterior regions corresponds to the developing brain and optic lobe. (D), sog mutant
embryo: Race expression is lost from the presumptive amnioserosa; the anterior Race expression expands into dorsolateral regions. (E),
embryo with an extra copy of dpp: Race is expressed in a broader pattern than wild-type. (F), tup expression in a wild-type embryo is detected
in the developing amnioserosa and dorsolateral regions of the dorsal ectoderm. (G), in a sog mutant embryo, the tup pattern is expanded
throughout the dorsal ectoderm. (H), tup expression in an embryo with an extra copy of dpp. The pattern is broader than wild-type.
the dorsal ectoderm of gastrulating embryos [8]. As an intracellular transducers of Dpp signaling, may function
with Zen to directly activate Race. Therefore, we testedintroduction to Dpp threshold responses, the expression
patterns of genes representative of two of these are whether Mad and Medea could bind directly to the Race
enhancer in vitro. DNase I footprinting assays with bac-shown in Figures 1C–1H. Expression of Race, a type
I threshold response, is dependent on peak Dpp/Scw terially expressed GST fusion proteins were used to
characterize the binding of Mad and Medea to threesignaling and is restricted to a narrow strip of cells in
the presumptive amnioserosa (Figure 1C). In sog mutant overlapping fragments of the Race enhancer. Mad and
Medea bind to two of the three enhancer fragmentsembryos, there is no Dpp/Scw gradient but instead a
uniform low level of Dpp/Scw signaling throughout the tested, and these are shown in Figure 2A. Three areas
are protected from DNase digestion in the presencedorsal epidermis. In these sog embryos, Race expres-
sion is lost from the presumptive amnioserosa, as the of Mad/Medea fusion proteins when compared to GST
protein alone or the lanes without any fusion protein.level of Dpp/Scw signaling is insufficient to activate
Race (Figure 1D; [11]). One of these footprints (site A) encompasses nucleo-
tides 28–41, and the other two sites, B and C, are adja-An example of a lower type II threshold is tup, which
is expressed in dorsal regions of the dorsal ectoderm cent to each other (nucleotides 464–483 and 484–502,
respectively). These adjacent binding sites are flankedas well as the presumptive amnioserosa (Figure 1F). tup
and Race were defined as distinct thresholds based, in by the previously identified Zen binding sites [12], as
depicted in Figure 2C. Mad and Medea recognize thepart, on their different responses to the absence of Sog
[8]. In embryos lacking sog, tup is expressed throughout same sites within the Race enhancer, consistent with
previous observations that Mad and Medea have over-the entire dorsal ectoderm, consistent with its ability to
be activated by lower levels of Dpp/Scw signaling (Fig- lapping binding specificities [14].
These binding sites were confirmed by gel retardationure 1G). Both Race and tup respond to alterations in
dpp dose and show expanded expression patterns assays using oligonucleotide probes containing the pro-
tected regions and a GST-Mad fusion protein. It appearsin embryos carrying an extra copy of dpp (Figures 1E
and 1H). that sites A and B are low-affinity binding sites, whereas
site C is higher affinity, as an increased amount of theIn this study, we focus on the peak threshold Race
to investigate why its expression is restricted to only a retarded complex is observed with probe C and Mad,
even though equimolar amounts of probe and the samenarrow strip at the dorsal midline. A 533 bp enhancer
has been identified previously that directs expression amount of Mad protein were used. As similar binding
data were obtained for Medea (data not shown), andof a linked lacZ reporter gene in transgenic embryos in
a similar pattern to that of endogenous Race (Figure 4A, given the overlapping binding specificities documented
for Mad and Medea [14], subsequent in vitro bindingcf. with Figure 1C; [12]).
assays were only performed using Mad.
Mad and Medea Bind to the Race Enhancer
Race expression is dependent on peak Dpp signaling, Characterization of the Mad and Medea
Binding Sitesand the Race enhancer contains three binding sites for
the Zerknu¨llt (Zen) transcription factor [12]. Zen, which Two previous studies have identified Mad/Medea con-
sensus binding sites, which together can be representedis itself activated by Dpp signaling in the presumptive
amnioserosa of gastrulating embryos [13], is essential by the Drosophila Smad consensus (DSC) GCCGC[C/G]
G[C/A] [14, 15]. In addition, some Drosophila Smad bind-for Race activation but not sufficient in the absence of
Dpp signaling [12]. This raised the possiblity that the ing sites [16] contain the Smad binding element (SBE),
AGAC, which was identified for human Smad4 [17]. OfMad and Medea transcription factors, which are the
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Figure 2. Identification of Smad Binding
Sites in the Race Enhancer
(A) DNase I footprinting assays using different
32P-labeled fragments of the Race enhancer
incubated in the absence of protein or with
GST, GST-Mad, or GST-Medea fusion pro-
teins as indicated. The protected regions are
highlighted by a bar to the right of the foot-
prints.
(B) Gel mobility shift assay with 32P-labeled
oligonucleotides corresponding to the three
protected regions identified in (A) and GST or
GST-Mad as indicated. Two different amounts
of GST-Mad were added; the thick bar repre-
sents the addition of twice as much Mad pro-
tein. Equimolar amounts of probes A, B, and
C of the same specific activity were added
to the reactions.
(C) Schematic representation showing the lo-
cation of the Mad/Medea binding sites (red)
and the previously identified Zen binding
sites (blue) in the Race enhancer.
the three binding sites identified in the Race enhancer, tive contributions of the DSC and SBE in site C to Mad
binding were analyzed by introducing point mutationsonly site C, the higher-affinity site, has a motif close to
the consensus with six out of eight matches, although into the C oligonucleotide (Figure 3D). As mutations out-
side the SBE inhibit binding, the SBE cannot be solelyB and C both contain perfect matches to the SBE. Site
A contains the sequence CGAC, which differs from the responsible for Mad binding. Instead, mutations in seven
positions of the 8 bp DSC reduce Mad binding, whereasSBE by one nucleotide, and a mutation at this position
in the SBE reduces but does not abolish binding of the m6 mutation, which increases GC richness, results
in more shifted complex. Therefore, it seems likely thatSmad4 [18]. In an attempt to eliminate Mad binding to
sites A–C, mutations were introduced into the Smad Mad binds to site C through the DSC.
From these results, mutant oligonucleotides were se-binding sites which disrupt GC sequences or the SBE.
The effect of introducing mutations into the Mad/ lected for further studies, including in vivo analysis in
transgenic embryos. Oligonucleotides Am, Bm, and CmMedea binding sites was tested in vitro using gel mobil-
ity shift assays and equimolar amounts of oligonucleo- were chosen, as these contain mutations that lead to
the greatest disruption of Smad binding in vitro, andtide probes. For site A, three mutant oligonucleotides
were tested: Am1 and Am2, which mutate GC sequences, these contain two blocks of mutations that each affect
binding when tested alone. Therefore, in terms of theand Am, which combines these mutations. The Am1 muta-
tions disrupt the SBE-related sequence CGAC. All of in vivo analysis, binding to these regions is minimized.
First, as a more stringent test of these mutant bindingthese mutations reduce binding, although the Am2 muta-
tion has the weakest effect (40% binding relative to A) sites, they were tested in gel shift competition experi-
ments. Binding of Mad to 32P-labeled wild-type oligonu-(Figure 3A). Both Am and Am1 greatly disrupt binding, with
slightly less Mad binding to oligonucleotide Am than Am1. cleotide probes, in the presence of increasing amounts
of the indicated unlabeled wild-type or mutant oligonu-These results suggest that, although both GC se-
quences contribute to Mad binding to region A, the ma- cleotides, was visualized (Figures 3F, 3H, and 3I). The
ability of excess unlabeled mutant Am oligonucleotidejor determinants for binding are the sequences mutated
in Am1. to compete for Mad binding to the labeled wild-type A
probe is 5-fold less than that of the unlabeled wild-Mutant oligonucleotides that remove GC sequences
were tested for site B (Bm, Bm1, and Bm2). In removing type A oligonucleotide (Figure 3F). This difference is
consistent with the small amount of residual binding ofGC sequences, the mutations in Bm2 also alter the last
nucleotide of the SBE. Therefore, the oligonucleotide Mad to the labeled mutant site Am (Figure 3A). The mu-
tant Bm oligonucleotide does not compete at all withBm3 was also tested, which contains only the single muta-
tion in the SBE. Of the mutant B oligonucleotides tested, labeled B probe for Mad even when present in a 100-
fold excess (Figure 3H). The mutant Cm oligonucleotideBm1 is the least effective at disrupting Mad binding, al-
though binding is substantially reduced (30% relative to competes with labeled site C for Mad with 10-fold less
efficiency than the corresponding wild-type sequenceB) (Figure 3B). The other three mutations greatly reduce
Mad binding, suggesting that the last base of the SBE (Figure 3I), confirming that the Cm site is compromised
with respect to its ability to bind Mad.and flanking bases are important contacts for Mad bind-
ing to region B.
For site C, mutations were introduced that eliminate Mad and Medea Are Essential Activators
of Race In Vivoeither of the two GC-rich sequences alone (Cm1, Cm2) or
together (Cm, Cm3). A small reduction in the amount of The preceding experiments have identified three Mad/
Medea binding sites in the Race enhancer in vitro, asshifted complex is observed for Cm2, whereas the other
mutations strongly disrupt binding (Figure 3C). The rela- well as mutations which strongly decrease Mad/Medea
Dpp Gradient Interpretation by Smad Affinity
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Figure 3. Mutation Analysis of the Race Enhancer Smad Binding Sites
Gel mobility shift assays with GST-Mad and labeled oligonucleotides as indicated under the autoradiographic image. Each lane within a gel
shift shows binding of the same amount of GST-Mad to equimolar amounts of labeled oligonucleotides of the same specific activity. In (A)–(D),
the sequences of the Smad binding sites tested in the gel shift assays are shown with mutations highlighted in red. The SBE in sites B and
C is shown in blue, and the DSC is also shown next to the C binding site, which matches it at 6 out of 8 positions. The introduced mutations
disrupt Mad binding to different extents. In (D), the mutations which affect Mad binding are shaded in yellow. In (E)–(G), little or no shifted
complex is observed with the Am or Bm oligonucleotides, and more shifted complex is detected with the Ae and Be oligonucleotides relative
to their wild-type controls. (F), (H), and (I) show gel mobility shift competition assays of Mad binding to the oligonucleotide indicated under
the autoradiographic image in the presence of competing amounts of unlabeled oligonucleotides. Competing oligonucleotides were added
at a 10 and 100 molar excess as indicated by the wedges. The Am, Bm, and Cm oligonucleotides compete less well than the A, B, and C
oligonucleotides, respectively. More efficient competition is observed with Ae and Be. More Mad was added to the reactions with labeled A
oligonucleotides in (F) than (A) and (E). In (I), BC is a longer oligonucleotide containing binding sites B and C, as these are adjacent in the
enhancer, and BeC differs from BC in that it contains the Be mutations. BeC is the best competitor of Mad binding to C. (J) shows sequences
of the higher-affinity Ae and Be Smad binding sites used in (E)–(I), with mutations shown in green.
binding. In order to determine the requirement of these (Figures 4C and 4D). The AB double mutant was also
tested to determine the activity of the enhancer con-Mad/Medea binding sites for Race activation in vivo,
these mutations were engineered into the Race en- taining only the higher-affinity site C. This enhancer can
only activate patchy lacZ expression in the presumptivehancer, which was tested using a lacZ reporter assay
in transgenic embryos. Mutation of binding site A has amnioserosa, similar to the Bm and Cm enhancers (Figure
4F). Mutation of all three Mad/Medea binding sites re-little effect on lacZ expression driven by the mutated
enhancer when compared to the wild-type enhancer sults in a complete loss of lacZ staining in the developing
amnioserosa (Figure 4E). The same result is obtained in(Figure 4B, cf. with 4A). In contrast, mutation of the Mad/
Medea binding sites B or C disrupts lacZ expression so transgenic embryos in which the enhancer has all three
binding sites deleted (data not shown). These resultsthat it becomes patchy along the anterior-posterior axis
Current Biology
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Figure 4. Smad Binding Sites Are Essential
for Race Enhancer Activity In Vivo
Dorsal views of transgenic embryos at the
initial phase of gastrulation stained with a
lacZ hybridization probe. Embryos contain
the lacZ reporter gene under the control of a
wild-type (A) or mutant (B–F) Race enhancer.
The sites mutated in the Race enhancer are
indicated in the bottom left corner, and the
sequences altered are shown in Figures 3A–
3C. (A), lacZ expression directed by the wild-
type Race enhancer is similar to the Race
pattern in a wild-type embryo (compare with
Figure 1C). Ectopic staining in the anterior is
due to vector sequences. (B), lacZ staining is
unaffected by mutation of site A. In (C), (D),
and (F), gaps appear in the lacZ pattern driven
by enhancers which contain mutations in
sites B, C, or AB. (E), lacZ expression in the
presumptive amnioserosa is lost in a trans-
genic embryo, which contains a Race en-
hancer with mutations in all three Smad bind-
ing sites.
demonstrate that the Mad and Medea binding sites we enhancer with higher-affinity Mad sites (Racee) directs
identified are necessary for Race activation in vivo and a lacZ expression pattern which is consistently broader
are consistent with Mad and Medea being essential acti- than that of the wild-type enhancer (Figure 5D, cf. with
vators of Race. 5A). In addition, the expression levels from the Racee
enhancer are higher (data not shown). The width of the
response from the Racee enhancer is similar to that ofHigher-Affinity Mad Binding Sites
the wild-type enhancer in embryos carrying three copiesThe three Mad/Medea sites identified are essential for
of dpp (Figure 5B). Expression from the Racee enhancerRace activation in the embryo, even though two of the
also broadens in the presence of an extra copy of dppSmad binding sites are low affinity. We tested the role
(Figure 5E), indicating that it is responsive to an increaseof enhancer Mad affinity in the transcriptional response
in Dpp/Scw signaling. Overall, the effect on expressionby altering the affinity of the Mad binding sites in the
of enhancing the affinity of two Mad binding sites in theRace enhancer. As site C has a higher affinity for Mad
enhancer 5- to 10-fold in wild-type embryos is equivalentthan sites A and B, these sites were engineered to be
to the effect on the Race enhancer of increasing activa-more similar to site C (Figure 3J).
tion of the pathway by introduction of an extra copy ofThe effect of mutating sites A and B to resemble C was
dpp.tested in gel shift competition assays. The enhanced site
Although the expression pattern from the Racee en-A (Ae) binds more Mad than an equimolar amount of
hancer is not as broad as the tup pattern, some otherwild-type site A (Figure 3E), and excess unlabeled Ae
type II responses, e.g., rhomboid, are themselves nar-competes with labeled probe A for Mad more efficiently
rower than tup. Therefore, to test whether the Raceethan an excess of unlabeled site A (Figure 3F). Similarly,
enhancer behaves like a type I or II threshold response,labeled site Be binds more Mad compared to B (Figure
it was crossed into embryos lacking sog. For all lines3G), and unlabeled Be is a more efficient competitor in
tested, expression from the Racee enhancer is expandedthe competition assay (Figure 3H). The amount of la-
beled oligonucleotide B-Mad complex observed in the in the dorsal ectoderm in a proportion of sog mutant
presence of a 10-fold excess of unlabeled Be is similar embryos (Figure 5F). This expression pattern is similar
to the amount of complex detected with 100-fold excess to that of Race in sog- embryos with an extra copy of
of site B. Consistent with the Be mutations increasing dpp [19]. The expanded expression observed with Racee
affinity, sites BeC are better at competing with labeled in the absence of sog is in marked contrast to the expres-
oligonucleotide C for Mad binding than sites BC, which sion pattern from the wild-type Race enhancer in sog
in turn compete more efficiently than site B alone (Figure mutant embryos, which is lost in the presumptive amnio-
3I). Overall, these results are consistent with the intro- serosa (Figure 5C). Instead, the expanded lacZ expres-
duced mutations increasing Mad affinity for the sites sion in sog embryos carrying the Racee-lacZ transgene
between 5- and 10-fold. is characteristic of the behavior of type II threshold re-
sponses, such as tup, in the absence of sog (Figure 1G).
This reveals the potential for transformation of a type IIncreases in Smad Affinity Broaden
threshold response to a type II response simply by alter-the Expression Pattern
ing the enhancer affinity for the Mad transcription factor.To test the effect of increasing Mad affinity on the thresh-
Overall, these results identify Mad affinity as an essentialold response in vivo, the mutations that enhance Mad
determinant in the cellular discrimination of the Dpp/affinity were introduced into the Race enhancer and
tested using the transgenic lacZ reporter assay. The Scw gradient into discrete thresholds.
Dpp Gradient Interpretation by Smad Affinity
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Figure 5. Increasing Smad Affinity Broadens
the Expression Pattern In Vivo
Dorsal views of transgenic embryos at the
onset of gastrulation hybridized with a lacZ
antisense RNA probe. Expression of the
transgene is shown in either wild-type em-
bryos (A, D), embryos carrying an extra copy
of dpp (B, E), or sog mutant embryos (C, F).
(A), lacZ expression in the developing amnio-
serosa directed by the wild-type Race en-
hancer. (B), same as (A), except the embryo
carries 3 copies of dpp. The lacZ pattern is
expanded. (C), lacZ pattern obtained with the
Race-lacZ transgene in embryos lacking sog.
Expression is lost from the presumptive amni-
oserosa. (D–F), embryos show lacZ expres-
sion under the control of a mutated Racee
enhancer containing higher-affinity Smad
binding sites. (D), lacZ expression expands
in a wild-type embryo carrying a Racee-lacZ
transgene (compare to the embryo in [A] car-
rying the Race-lacZ transgene). Staining is similar to the wild-type Race enhancer pattern in an embryo carrying an extra copy of dpp (shown
in [B]). (E), lacZ expression expands as the Racee enhancer responds to an increased dpp dose. (F), Racee activates lacZ expression in the
dorsal ectoderm in a sog mutant embryo. lacZ staining with Racee in sog embryos is somewhat variable; however, all transgenic lines tested
show this kind of expansion in a proportion of the mutant embryos.
Discussion mutant embryos [8, 9], demonstrating that Brk repres-
sion is not a major contributor to the establishment of
these type II threshold responses.Molecular Mechanism of Dpp
Threshold Responses Based on the results presented here, we predict that
at least some type II thresholds that are expressed inThe embryonic dorsal ectoderm is subdivided into dis-
tinct cell types by the Dpp/Scw gradient through the broader patterns than that directed by Racee will depend
on yet higher enhancer affinity for Smads. These en-activation of at least three different thresholds of gene
activity [8]. The extracellular Dpp/Scw gradient leads to
a peak of nuclear Mad and Medea in the presumptive
amnioserosa of gastrulating embryos flanked by a nar-
row plateau of lower concentration [13, 20, 21], which
correlates with the type I and II threshold responses,
respectively. We have provided evidence that Mad and
Medea directly activate the peak type I threshold Race
in vivo. Furthermore, increasing the affinity of the Smad
binding sites in the enhancer can alter the threshold
response to the extracellular morphogen gradient (Fig-
ure 6).
On the basis of these results, we suggest that the
high nuclear Smad concentration at the dorsal midline
is sufficient to occupy the Smad binding sites in the
Race enhancer, two of which are low affinity, whereas
the lower levels of nuclear Smads detected in the dor-
somedial ectoderm are not. Increasing the affinity of the
Smad sites in the Racee enhancer allows occupancy at
lower Smad concentrations and hence a wider expres-
sion pattern characteristic of a type II threshold. There-
fore, expression of Race is restricted to the presumptive
Figure 6. Summary of the Role of Smad Affinity in Interpretation of
amnioserosa due to low Smad affinity in its enhancer, the Dpp Gradient
and we speculate that this will also be true for at least
Diagrams representing a cross-section through the embryo.
some other type I thresholds. (A) The Dpp gradient in the dorsal ectoderm is shown in green, and
It has been suggested previously that there may be the neuroectoderm and mesoderm are in blue and red, respectively
(compare to Figure 1A).an opposing Brk gradient in the dorsal ectoderm which
(B) The light blue shading represents the expression pattern directedis dependent on limited diffusion of Brk protein in the
by the wild-type Race enhancer, which is restricted to the presump-syncitial nuclei of the precellular embryo. Although Brk
tive amnioserosa. The low (L) and high (H)-affinity Mad binding sitescan directly repress tup, expression of tup is unaffected
identified in the enhancer are shown.
in brk mutant embryos at the onset of gastrulation [8]. (C) Increasing the affinity of two Mad binding sites in the enhancer
Other type II thresholds including rhomboid and leads to a widening of the expression pattern, which extends into the
dorsal regions of the dorsal epidermis, as indicated by the arrows.u-shaped also have wild-type expression patterns in brk
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hancers may contain a different orientation of Smad Morphogen Gradient Interpretation
Bicoid (Bcd) and Dorsal (Dl) are maternally expressedbinding sites, as orientation has previously been shown
transcription factors that are determinants of the ante-to affect the affinity of Smad4 binding [22], or a greater
rior-posterior and dorsal-ventral axes, respectively, andnumber of high affinity sites. An in silico analysis of the
have many of the properties of morphogens. In the pre-tup genomic region identifies a 500 bp region in the
cellular embryo, the Bcd and Dl transcription factor gra-large first intron that contains six putative high-affinity
dients are interpreted by binding site affinity [30, 31]. OurSmad binding sites in addition to at least three potential
results now demonstrate that transcriptional activatorBrk binding sites. Based on our analysis here, it would
affinity can also be used to measure the extracellularseem that this region, which is conserved in the D. pseu-
concentration of a morphogen postcellularization sodoobscura tup first intron, is a good candidate for the
that dose-dependent gene expression patterns can betup enhancer (S.J.W. and H.L.A., unpublished data).
generated.Studies in vertebrates have indicated that Smads have
Gradients of TGF- signaling molecules are used tolow specificity and affinity for DNA, which can be in-
pattern many fields of cells during development. Forcreased in the presence of a Smad binding partner [23].
example, Xenopus BMP4, the Dpp ortholog, acts as aThe results presented here demonstrate that alterations
morphogen to pattern the ectoderm, and Smad1 overex-in Smad affinity alone can change the threshold re-
pression mimics excess BMP4 [32]. A vertebrate or-sponse, but cooperative DNA binding with a Smad bind-
tholog of Brk has not been described and, althoughing partner may also be important. It is possible that
Drosophila Brk can antagonize BMP4 signaling in Xeno-genes with broader expression patterns have binding
pus [33], it is unclear if an unrelated protein that performssites for different Smad binding partners in their en-
an analagous function in vertebrates exists. Therefore,hancers. We note that two of the three Smad binding
our results, which describe how different readouts cansites we identified in the Race enhancer are flanked by
be obtained from a Dpp/BMP gradient solely by changesZen binding sites. As Mad and Medea interact with Zen
in Smad affinity, may be especially relevant to TGF-in the yeast 2-hybrid assay ([24]; S.J.W. and H.L.A, un-
signaling readouts in vertebrates. Moreover, they iden-published data), Zen may function as a Smad binding
tify a possible strategy for interpretation of extracellularpartner for Race activation. However, misexpression of
gradients of different classes of signaling molecules.Zen using the tolloid or Kru¨ppel enhancers does not
expand wild-type Race expression or the lacZ pattern
directed by the Race or Racee enhancers (S.J.W. and Conclusions
H.L.A, unpublished data). A general theme during development is that cells re-
spond to morphogen gradients by executing specific
gene expression programs in response to different con-
centrations of morphogen. Our results identify SmadDpp Gradient Interpretation in the Embryo
activator affinity as a key component in the nuclear inter-versus Wing Disk
pretation of the extracellular Dpp gradient, as increasingThe importance of Smad affinity in establishment of the
enhancer Smad affinity is sufficient to alter the Dppdorsal ectoderm Dpp threshold responses contrasts
gradient threshold response. Therefore, the extracellularwith the mechanism for setting the limits of the expres-
Dpp gradient readouts in the embryo can be establishedsion patterns of Dpp target genes in the wing disk. In
by a simpler, more direct mechanism than that usedthe wing disk, a localized source of Dpp diffuses to
in the wing disk which involves generation and thenform a gradient which activates target genes, eg spalt,
interpretation of a reciprocal repressor gradient. As itoptomotor-blind and vg, in nested domains with differ-
has yet to be established how the extracellular concen-ent widths of expression [6]. Dpp signaling directly re-
tration of other morphogens, e.g., Wg and Hh, is inter-presses Brk to create an opposing Brk gradient [25] and
preted by cells to generate different programmed tran-it appears that sensitivity to Brk repression is the major
scriptional responses, our results offer a framework fordeterminant of the Dpp threshold responses [26]. As
these studies.Brk and Mad can compete for overlapping binding sites
[13, 27, 28], Smad affinity may play a role in the genera-
Experimental Procedurestion of a subset of wing Dpp thresholds by restricting
Brk binding to common sites depending on their relative DNase I Footprinting
affinities for Brk and the Smads. However, Brk can also GST-Mad (amino acids 1–241) and GST-Medea (amino acids 1–265)
mediate repression by binding to sites in an enhancer DNA binding domain fusion proteins were purified from Escherichia
coli BL21 tranformed with pGEX plasmids (Amersham) containingwhich are separate from the Smad activator sites [29]
Mad and Medea fragments equivalent to those described previouslyand by recruiting specific corepressors [6], suggesting
[14, 15]. E. coli BL21 transformed with pGEX was used to purify GSTthat for other wing Dpp threshold responses, Brk affinity
as a control. Proteins were purified according to the manufacturer’s
alone will be the critical factor. In contrast to the wing protocol (Amersham). Solid-phase DNase I footprinting was per-
disk, many Dpp threshold responses in the early embryo formed as described previously [34]. PCR fragments of the Race
enhancer [12] were generated using pBS-Race as template andare insensitive to Brk repression [8, 9]; therefore, Dpp
specific primer pairs. Fragments corresponding to nucleotidestarget genes must use an alternative mechanism for
1–183, 141–389, and 357-533 were tested. For each fragment, oneinterpreting the extracellular morphogen concentration.
of the oligonucleotides used in the PCR reaction was labeled at its
Our results suggest that specification of at least some 5 end with [-32P-]ATP (5000 Ci/mmol, Amersham) and T4 poly-
type I and II thresholds in the embryo depends on varia- nucleotide kinase, whereas the other oligonucleotide was synthe-
sized with a biotin group at its 5 end. The following modificationstions in Smad affinity at target gene enhancers.
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were made to the published footprinting protocol: binding reactions 5. Chen, Y., and Schier, A.F. (2000). The zebrafish Nodal signal
Squint functions as a morphogen. Nature 411, 607–610.between labeled oligonucleotides and proteins contained 12.5 mM
HEPES (pH 7.9), 2% PVA, 10% glycerol, 1 mM DTT, 100 g/ml 6. Affolter, M., Marty, T., Vigano, M.A., and Jazwinska, A. (2001).
Nuclear interpretation of Dpp signaling in Drosophila. EMBO J.BSA, 1 mM EDTA (pH 8.0), and 50 mM KCl; DNase digestion was
performed at 21C for 2 min with 0.0025U DNase I. An aliquot of the 20, 3298–3305.
7. Ashe, H.L. (2002). BMP Signalling: Visualisation of the Sog pro-labeled oligonucleotide was also used in a dideoxy sequencing
reaction according to the manufacturer’s protocol (Sequenase V2.0, tein gradient. Curr. Biol. 12, R273–R275.
8. Ashe, H.L., Mannervik, M., and Levine, M. (2000). Dpp signalingAmersham), and a proportion of this reaction was run on a 5% urea-
polyacrylamide gel along with the footprinting reactions. thresholds in the dorsal ectoderm of the Drosophila embryo.
Development 127, 3305–3312.
9. Jazwinska, A., Rushlow, C., and Roth, S. (1999). The role ofGel Mobility Shift Assays
brinker in mediating the graded response to Dpp in early Dro-Oligonucleotides, designed to have CTAG overhangs at each 5
sophila embryos. Development 126, 3323–3334.end, were annealed and labeled using [-32P-]CTP (3000 Ci/mmol,
10. Zhang, H., Levine, M., and Ashe, H.L. (2001). Brinker is a se-Amersham) and Klenow or [-32P-]ATP (5000 Ci/mmol, Amersham)
quence-specific transcriptional repressor in the Drosophila em-and T4 polynucleotide kinase. Labeled oligonucleotides were puri-
bryo. Genes Dev. 15, 261–266.fied over a Sephadex column (ProbeQuant G-50 micro columns,
11. Ashe, H.L., and Levine, M. (1999). Local inhibition and long-Amersham). Gel shift and competition assays were performed as
range enhancement of Dpp signal transduction by Sog. Naturedescribed [14]. The sequences of the oligonucleotides tested are
398, 427–431.listed in Figures 3A–3D and 3J; the CTAG nucleotides added at each
12. Rusch, J., and Levine, M. (1997). Regulation of a dpp target5 end are not shown. The sequence in the A oligonucleotides is
gene in the Drosophila embryo. Development 124, 303–311.slightly longer than the footprinted region to facilitate their an-
13. Rushlow, C., Colosimo, P.F., Lin, M.C., Xu, M., and Kirov, N.nealing.
(2001). Transcriptional regulation of the Drosophila gene zen by
competing Smad and Brinker inputs. Genes Dev. 15, 340–351.
Plasmid Construction, Transgenic Assays, 14. Xu, X., Yin, Z., Hudson, J.B., Ferguson, E.L., and Frasch, M.
and Drosophila Stocks (1998). Smad proteins act in combination with synergistic and
The plasmid pBS-Race was constructed by PCR amplification of antagonistic regulators to target Dpp responses to the Drosoph-
the Race enhancer [12] using oligonucleotides which contain an ila mesoderm. Genes Dev. 12, 2354–2370.
EcoR1 site at their 5 end, followed by insertion of the EcoR1 Race 15. Kim, J., Johnson, K., Chen, H.J., Carroll, S., and Laughon, A.
enhancer fragment into EcoR1-digested pBluescript SK	. Mutagen- (1997). Drosophila Mad binds to DNA and directly mediates
esis of the enhancer Smad binding sites was performed using a activation of vestigial by Decapentaplegic. Nature 388, 304–308.
PCR-based strategy with pBS-Race as template. The mutant en- 16. Knirr, S., and Frasch, M. (2001). Molecular integration of induc-
hancers were then inserted as EcoR1 fragments into the unique tive and mesoderm-intrinsic inputs governs even-skipped en-
EcoR1 site of the –42evelacZ plasmid [35]. All mutations were veri- hancer activity in a subset of pericardial and dorsal muscle
fied by DNA sequencing. The –42evelacZ-Race reporter plasmids progenitors. Dev. Biol. 238, 13–26.
were introduced into yw67c23 embryos as described previously [36]. 17. Zawel, L., Dai, J.L., Buckhaults, P., Zhou, S., Kinzler, K.W., Vo-
At least three independent lines were tested for each transgene. gelstein, B., and Kern, S.E. (1998). Human Smad3 and Smad4 are
The expression patterns of the lacZ reporter gene, Race, and tup sequence-specific transcription activators. Mol. Cell 1, 611–617.
were visualized by RNA in situ hybridization with digoxigenin-labeled 18. Jonk, L.J., Itoh, S., Heldin, C.H., ten Dijke, P., and Kruijer, W.
antisense RNA probes as described [36]. All embryos in the figures (1998). Identification and functional characterization of a Smad
are oriented with anterior to the left. binding element (SBE) in the JunB promoter that acts as a
The Drosophila stocks used were as follows: decapentaplegic, transforming growth factor-beta, activin, and bone morphoge-
dppHin37/GlaDp(2;2)DTD48; short gastrulation, sogS6/FM7c; and netic protein-inducible enhancer. J. Biol. Chem. 273, 21145–
yw67c23. The Race and Racee enhancers were analyzed in sog and 3 21152.
dpp embryos by crossing sogS6/FM7c and dppHin37/GlaDp(2;2)DTD48 19. Decotto, E., and Ferguson, E.L. (2001). A positive role for Short
females, respectively, with males carrying the relevant transgene. gastrulation in modulating BMP signaling during dorsoventral
patterning in the Drosophila embryo. Development 128, 3831–
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